Clinical trial · Observational
Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs Resection
NCT06714773CI-TRIAL-00083298completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to assess the oncological outcomes in patients diagnosed with grade 2 chondrosarcoma, treated with intralesional curettage, stratified into two cohorts: those subjected to follow up monitoring and those who have undergone subsequent surgical intervention.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chondrosarcoma, Grade 2 | Chondrosarcoma, Grade 2 | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Tumor recurrence(%)
- timeFrame
- 3 months, 6 months, 1 year, 2 years, 5 years, 10 years
- description
- It will be measured by: X-Rays, CT, MRI, PET CT scan
- measure
- distant metastasis (%)
- timeFrame
- 3 months, 6 months, 1 year, 2 years, 5 years, 10 years
- description
- It will be measured by: CT scan of the lungs, PET CT scan
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with a diagnosis of grade 2 chondrosarcoma of the appendiceal skeleton in the definitive specimen; * Patients treated with intralesional curettage surgery; * Patients aged \>=18 years; * Patients who were treated between 01/01/2008 and 31/12/2020. Exclusion Criteria: * Patients diagnosed with grade 1 or 3 chondrosarcoma on the histological diagnosis of the operative specimen. * Patients undergoing wide resection as the primary treatment. * Patients with less than 12 months follow-up.
References
Publications (0)
Data not yet available
No reference posted for this study.